Senior Analyst applicants have rated the interview process at ClearView Healthcare Partners with 2.7 out of 5 (where 5 is the highest level of difficulty) and assessed their interview experience as 67% positive. To compare, the company-average is 63.7% positive. This is according to Glassdoor user ratings.
Candidates applying for Senior Analyst roles take an average of 21 days to get hired, when considering 3 user submitted interviews for this role. To compare, the hiring process at ClearView Healthcare Partners overall takes an average of 18 days.
Common stages of the interview process at ClearView Healthcare Partners as a Senior Analyst according to 3 Glassdoor interviews include:
One on one interview: 100%
Here are the most commonly searched roles for interview reports -
I applied online. I interviewed at ClearView Healthcare Partners in Apr 2022
Interview
Experience highly depends on the interviewers. Had two great interviewers, and everything was great. But another guy was rushing and clearly not devoted to the interview and didn't care about the poor internet/audio connection he had.
Entry to market cases
Final round is more conversational— don’t be too structured
Interviewees were polite but did not pay attention while giving the interview and were constantly staring at a different monitor
I applied through college or university. The process took 3 weeks. I interviewed at ClearView Healthcare Partners
Interview
I applied online through my schools on campus recruiting process process. This interviewer was a graduate of my school and was very friendly and sociable.
I had a second round interview a week later in the office. I had 5 30 minute interviews and lunch with other prospective candidates. 2 were with newer employers and 3 were with upper management.
I heard back within a few days.
Overall the process went very smoothly and they were very accomodating. The office culture is very friendly. There is a large focus on drinking that seemed present.
Interview questions [1]
Question 1
Lots of typical healthcare cases: should we buyout a small company making this drug or a small company making this drug, how much should we price this antibiotic at?